• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

When Less Is More: The Comparative Effectiveness of Partial Versus Radical Nephrectomy.

作者信息

Gershman Boris, Boorjian Stephen A

机构信息

Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Department of Urology, Mayo Clinic, Rochester, MN, USA.

出版信息

Eur Urol. 2021 Jun;79(6):781-782. doi: 10.1016/j.eururo.2021.03.010. Epub 2021 Mar 26.

DOI:10.1016/j.eururo.2021.03.010
PMID:33773872
Abstract
摘要

相似文献

1
When Less Is More: The Comparative Effectiveness of Partial Versus Radical Nephrectomy.少即是多：部分肾切除术与根治性肾切除术的比较疗效
Eur Urol. 2021 Jun;79(6):781-782. doi: 10.1016/j.eururo.2021.03.010. Epub 2021 Mar 26.
2
Re: Partial Nephrectomy versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-Analysis of Comparative Studies.关于：临床T1b和T2期肾肿瘤的部分肾切除术与根治性肾切除术：比较研究的系统评价和荟萃分析
J Urol. 2017 Dec;198(6):1204-1206. doi: 10.1016/j.juro.2017.09.050. Epub 2017 Sep 19.
3
Editorial Comment to Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.非转移性病理T3a期肾细胞癌行部分肾切除术与根治性肾切除术的编辑评论：一项多机构比较分析
Int J Urol. 2014 Apr;21(4):358. doi: 10.1111/iju.12292. Epub 2013 Oct 9.
4
Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.部分肾切除术与根治性肾切除术治疗非转移性 T3a 期肾细胞癌：多机构比较分析。
Int J Urol. 2014 Apr;21(4):352-7. doi: 10.1111/iju.12283. Epub 2013 Sep 30.
5
Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606-17.
Eur Urol. 2017 Sep;72(3):e59-e60. doi: 10.1016/j.eururo.2017.06.006. Epub 2017 Jun 16.
6
Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
Eur Urol. 2017 Nov;72(5):e127-e128. doi: 10.1016/j.eururo.2017.05.017. Epub 2017 May 22.
7
[Extracorporeal partial nephrectomy, is it worth?].[体外部分肾切除术，值得做吗？]
Urologiia. 2016 Aug(3):62-69.
8
Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation.T1a 期肾细胞癌行开放性与腹腔镜及部分性与根治性肾切除术的比例：基于人群的评估。
Int J Urol. 2013 Nov;20(11):1064-71. doi: 10.1111/iju.12110. Epub 2013 Feb 19.
9
Re: Partial Nephrectomy Versus Radical Nephrectomy for cT2 or Greater Renal Tumors: A Systematic Review and Meta-analysis.关于：cT2期及以上肾肿瘤行部分肾切除术与根治性肾切除术的系统评价和荟萃分析
Eur Urol. 2020 Feb;77(2):283-284. doi: 10.1016/j.eururo.2019.08.038. Epub 2019 Oct 13.
10
Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.对Jae Heon Kim和Benjamin I. Chung致编辑的信的回复，信的主题为：Maria Carmen Mir、Ithaar Derweesh、Francesco Porpiglia、Homayoun Zargar、Alexandre Mottrie、Riccardo Autorino。临床T1b和T2期肾肿瘤的部分肾切除术与根治性肾切除术：比较研究的系统评价和荟萃分析。《欧洲泌尿外科杂志》2017年；71卷：606 - 17页
Eur Urol. 2017 Nov;72(5):e129-e130. doi: 10.1016/j.eururo.2017.05.010. Epub 2017 May 18.

引用本文的文献

1
Tylectomy Safety in Salvage of Eyes with Retinoblastoma.视网膜母细胞瘤眼球挽救术中眼球切除术的安全性
Cancers (Basel). 2021 Nov 22;13(22):5862. doi: 10.3390/cancers13225862.